CDO1 and gastric cancer: CDO1 gene hypermethylation could predict poorer prognosis of pStage II / III gastric cancer without adjuvant chemotherapy than CDO1 gene hypomethylation (5-year OS 53.8% / 76.3% in the H / L group, respectively) (p = 0.0067) (Fig 2E, left panel).